The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LEANOX: Lean body mass normalization of oxaliplatin-based chemotherapy for patients with stage III colon cancer treated in adjuvant setting: Impact on oxaliplatin-induced sensitive neurotoxicity—A multicenter phase II randomized trial.
 
Eric Assenat
Consulting or Advisory Role - AstraZeneca; Bayer; Boston Scientific; Incyte; Ipsen; SERVIER
 
Meher BEN Abdelghani
No Relationships to Disclose
 
Maeva Monnier
No Relationships to Disclose
 
Herve Perrier
No Relationships to Disclose
 
Faiza Khemissa
Honoraria - Roche; Roche; SERVIER
Travel, Accommodations, Expenses - Ipsen; Roche; Roche; Sanofi; SERVIER
 
Romain Desgrippes
No Relationships to Disclose
 
Marie-Pierre Galais
No Relationships to Disclose
 
Yves Rinaldi
No Relationships to Disclose
 
Come Lepage
Honoraria - Amgen; Ipsen; Pierre Fabre
Consulting or Advisory Role - Advanced Accelerator Applications; Novartis; Novartis
Travel, Accommodations, Expenses - Ipsen; Ipsen; Merck Serono; Novartis
 
Raphael Tetreau
No Relationships to Disclose
 
Pierre Senesse
No Relationships to Disclose